Status:
COMPLETED
A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Herpes Zoster
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether the investigational zoster vaccine has a comparable immune response (the body's ability to protect against disease) and safety profile when given conc...
Eligibility Criteria
Inclusion
- Adults 50 years of age or older
Exclusion
- Prior history of Herpes Zoster (shingles)
- Prior receipt of varicella or zoster vaccine
- Immunosuppressed
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2006
Estimated Enrollment :
763 Patients enrolled
Trial Details
Trial ID
NCT00231816
Start Date
September 1 2005
End Date
March 1 2006
Last Update
September 21 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.